MedTrace Logo

Aortic Valve Replacement With Trifecta(TM)

NCT00475267 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 203

Last updated 2019-02-04

No results posted yet for this study

Summary

The purpose of this study is to confirm the clinical safety and effectiveness of the Trifecta valve.

Conditions

  • Aortic Valve Insufficiency
  • Regurgitation, Aortic Valve
  • Aortic Valve Incompetence
  • Aortic Valve Stenosis

Interventions

DEVICE

Trifecta aortic heart valve

Intended as a replacement for a diseased, damaged, or malfunctioning aortic heart valve.

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Hartzell Schaff, MD · Mayo Clinic

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2010-07-31
Completion
2012-01-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00475267 on ClinicalTrials.gov